Dow Down1.40% Nasdaq Down1.59%

Synta Pharmaceuticals Corp. (SNTA)

-NGM
3.04 0.03(1.00%) Oct 1, 4:00PM EDT
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Net Income (90,192) (62,790) (47,380)
Operating Activities, Cash Flows Provided By or Used In
Depreciation516  738  1,464  
Adjustments To Net Income6,030  3,322  3,354  
Changes In Accounts Receivables -   -  116  
Changes In Liabilities7,165  4,647  (4,459)
Changes In Inventories -   -   -  
Changes In Other Operating Activities(930)(52)(395)
Total Cash Flow From Operating Activities (77,411) (54,135) (47,300)
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(769)(505)(690)
Investments(23,884)(9,438)10,019  
Other Cash flows from Investing Activities -   -   -  
Total Cash Flows From Investing Activities (24,653) (9,943) 9,329  
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid -   -   -  
Sale Purchase of Stock38,735  66,216  27,581  
Net Borrowings30,307  49,299  9,155  
Other Cash Flows from Financing Activities -   -   -  
Total Cash Flows From Financing Activities 69,042   115,515   36,736  
Effect Of Exchange Rate Changes -   -   -  
Change In Cash and Cash Equivalents (33,022) 51,437   (1,235)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.